Rye Pharmaceuticals is categorized under Drugs, Proprietaries, and Sundries in Lakewood, CO and active since 2010.
Rye Pharmaceuticals was established in 2010, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Drugs, Proprietaries, and Sundries business, which does work in the B2C market, and is classified as a Drugs, Proprietaries, and Sundries, under code number 424210 by the NAICS.
If you are seeking more information, feel free to contact Bob Johnson at the company’s single location by writing to 2328 South Eldridge St, Lakewood, Colorado CO 80228 or by phoning (303) 984-9718. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Rye Pharmaceuticals |
| Contact Person: | Bob Johnson |
| Address: | 2328 South Eldridge St, Lakewood, Colorado 80228 |
| Phone Number: | (303) 984-9718 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Drugs, Proprietaries, and Sundries |
| SIC Code: | 5122 |
| NAICS Code: | 424210 |
| Share This Business: |
Rye Pharmaceuticals was started in 2010 to provide professional Drugs, Proprietaries, and Sundries under the SIC code 5122 and NAICS code 424210. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Bob Johnson for inquiries that concern Rye Pharmaceuticals by calling the company number (303) 984-9718, as your correspondence is most welcome. Additionally, the physical location of the single location of Rye Pharmaceuticals can be found at the coordinates 39.674001,-105.156699 as well as the street address 2328 South Eldridge St in Lakewood, Colorado 80228.
For its online presence, you may visit Rye Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.